cbdMD, Inc.
YCBD
$0.72
-$0.01-1.12%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.27% | 2.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.27% | 2.47% | |||
| Cost of Revenue | 3.70% | 9.46% | |||
| Gross Profit | 8.07% | -1.90% | |||
| SG&A Expenses | -0.01% | -4.94% | |||
| Depreciation & Amortization | -6.37% | -6.46% | |||
| Other Operating Expenses | -66.45% | -32.78% | |||
| Total Operating Expenses | -1.91% | -1.90% | |||
| Operating Income | 58.25% | 24.20% | |||
| Income Before Tax | 58.37% | 24.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 58.37% | 24.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 58.37% | 24.05% | |||
| EBIT | 58.25% | 24.20% | |||
| EBITDA | 90.37% | 32.14% | |||
| EPS Basic | 52.44% | 64.28% | |||
| Normalized Basic EPS | 58.44% | 51.03% | |||
| EPS Diluted | 52.44% | 64.28% | |||
| Normalized Diluted EPS | 58.44% | 51.03% | |||
| Average Basic Shares Outstanding | 0.47% | 54.96% | |||
| Average Diluted Shares Outstanding | 0.47% | 54.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||